THE PREVALENCE AND ETIOLOGY OF LONG-TERM L-DOPA SIDE-EFFECTS IN ELDERLY PARKINSONIAN-PATIENTS

被引:17
|
作者
WILSON, JA
SMITH, RG
机构
关键词
D O I
10.1093/ageing/18.1.11
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
引用
收藏
页码:11 / 16
页数:6
相关论文
共 50 条
  • [1] L-DOPA AND THE SECRETION OF SEBUM IN PARKINSONIAN-PATIENTS
    STREIFLER, M
    AVRAMI, E
    RABEY, JM
    EUROPEAN NEUROLOGY, 1980, 19 (01) : 43 - 48
  • [2] URINARY METABOLITES OF L-DOPA DURING LONG-TERM TREATMENT OF PARKINSONIAN PATIENTS WITH L-DOPA
    SIIRTOLA, T
    HIRVIAHO, L
    SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1973, 31 : 14 - 14
  • [3] URINARY METABOLITES OF L-DOPA DURING LONG-TERM TREATMENT OF PARKINSONIAN PATIENTS WITH L-DOPA
    SIIRTOLA, T
    SONNINEN, V
    RINNE, UK
    ACTA PHARMACOLOGICA ET TOXICOLOGICA, 1972, 31 : 66 - &
  • [4] THE USE OF TIAPRIDE IN A THERAPEUTIC TRIAL OF DYSKINESIAS OCCURRING IN PARKINSONIAN-PATIENTS FOLLOWING LONG-TERM TREATMENT WITH L-DOPA
    ARLAZOROFF, A
    FLECHTER, S
    GOLDENBERG, E
    BLEICHER, Z
    ISRAEL JOURNAL OF MEDICAL SCIENCES, 1984, 20 (07): : 649 - 649
  • [5] CARDIOPRESSOR ADAPTABILITY IN PARKINSONIAN-PATIENTS - THE EFFECTS OF COMBINED L-DOPA + NICERGOLINE THERAPY
    MICIELI, G
    MARTIGNONI, E
    CAVALLINI, A
    PACCHETTI, C
    NAPPI, G
    CLINICAL TRIALS JOURNAL, 1987, 24 (05) : 404 - 416
  • [6] PLASMA-CATECHOLAMINES AND THE ACUTE EFFECTS OF ORAL L-DOPA IN PARKINSONIAN-PATIENTS
    ROSSOR, M
    WATKINS, J
    BROWN, MJ
    REID, JL
    DOLLERY, CT
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1979, 9 (02) : 30 - 30
  • [7] PLASMA-CATECHOLAMINES AND THE ACUTE EFFECTS OF ORAL L-DOPA IN PARKINSONIAN-PATIENTS
    BROWN, MJ
    DOLLERY, CT
    REID, JL
    ROSSOR, M
    WATKINS, J
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1979, 8 (04) : P388 - P388
  • [8] DOPAMINE L-DOPA RATIO IN CEREBROSPINAL-FLUID OF PARKINSONIAN-PATIENTS TREATED WITH L-DOPA + BENSERAZIDE
    FEKETE, M
    TARCZY, M
    BIHARI, K
    KATONA, G
    PSYCHOPHARMACOLOGY, 1984, 82 (1-2) : 93 - 94
  • [9] L-DOPA LONG-TERM TREATMENT IN PARKINSONS-DISEASE - AGE-RELATED SIDE-EFFECTS
    PEDERZOLI, M
    GIROTTI, F
    SCIGLIANO, G
    AIELLO, G
    CARELLA, F
    CARACENI, T
    NEUROLOGY, 1983, 33 (11) : 1518 - 1521
  • [10] PERIPHERAL L-DOPA PHARMACOKINETICS IN UNTREATED, STABLE, AND FLUCTUATING PARKINSONIAN-PATIENTS
    GANCHER, ST
    NUTT, JG
    WOODWARD, W
    NEUROLOGY, 1986, 36 (04) : 216 - 216